You are here
Novosanis is attending the IPVC 2018 conference in Sydney, Australia from October 2 to October 6, 2018. Excited to present our latest results on the Colli-Pee device suited for (home-based) collection of first-void urine allowing for detection of Human Papilloma Virus.
We are excited to join the 2018 meeting in Sydney, Australia. Australia has been at the forefront of HPV research from key innovations in immunology and vaccine development through to the implementation of large scale vaccination initiatives and an upcoming imminent transition to HPV-based cervical screening. The meeting will combined with AOGIN, and plan a strong regional focus on HPV control in the Asia-Pacific Region.
Join us at booth 23 and talk to our Product & Business Developer, Quinten Van Avondt and our Clinical Affairs Associate, Joke Donné.